Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

Average Wall Street price targets imply a 107.8% upside for Vor Biopharma (VOR). A positive trend in earnings estimate revisions could support upside, but the usefulness of the price-target metric is questioned, making any move speculative and dependent on future fundamentals or catalysts.

Analysis

Average Wall Street price targets imply a 107.8% upside for Vor Biopharma (VOR). A positive trend in earnings estimate revisions could support upside, but the usefulness of the price-target metric is questioned, making any move speculative and dependent on future fundamentals or catalysts.